Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.
about
Immunotherapy against metastatic bladder cancer by combined administration of granulocyte macrophage-colony stimulating factor and interleukin-2 surface modified MB49 bladder cancer stem cells vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 February 2017
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immunotherapy against metastat ...... der cancer stem cells vaccine.
@en
Immunotherapy against metastat ...... der cancer stem cells vaccine.
@nl
type
label
Immunotherapy against metastat ...... der cancer stem cells vaccine.
@en
Immunotherapy against metastat ...... der cancer stem cells vaccine.
@nl
prefLabel
Immunotherapy against metastat ...... der cancer stem cells vaccine.
@en
Immunotherapy against metastat ...... der cancer stem cells vaccine.
@nl
P2093
P2860
P921
P356
P1433
P1476
Immunotherapy against metastat ...... der cancer stem cells vaccine.
@en
P2093
Chun-Yan Wang
Qing-Jun Chu
Simei Chen
Xiaomin Zhan
P2860
P304
P356
10.1002/CAM4.1023
P407
P577
2017-02-16T00:00:00Z